Background
Recommendations of clinical guidelines for the treatment of critical limb ischemia (CLI) are based on randomized controlled trials [1] . Surgery using different grafts (venous or prosthetic) is in competition with percutaneous angioplasty. Progress of endoluminal techniques has brought certain authors to think that angioplasty is now the first treatment of critical limb ischemia [2] . 
Materials and methods

Results
We have a 30 day mortality rate of 2.7%, graft occlusion 9% and amputation 2.6%. Comparing our results to those of the literature for venous or prosthetic bypasses and distal angioplasties, we remain convinced of the high efficiency, in the long run, of infra-popliteal venous bypass grafts. Meanwhile, recent data on distal angioplasties are promising and in constant progress. [2] . 
